Literature DB >> 3510396

Potent ulcerogenic actions of platelet-activating factor on the stomach.

A C Rosam, J L Wallace, B J Whittle.   

Abstract

Platelet-activating factor (PAF) is an endogenous phospholipid which has been implicated as a mediator of allergic and inflammatory processes. It is synthesized and released by neutrophils, platelets, macrophages, monocytes, basophils and endothelial cells, and is a potent platelet-aggregating agent, a vasodilator, increases vascular permeability, stimulates neutrophil aggregation and degranulation and induces release of lysosomal enzymes. A role for PAF in the hypotension associated with endotoxin shock and in necrotizing enterocolitis has recently been suggested. As there is an association between septic shock and acute gastric damage, we propose that PAF is an endogenous mediator of ulceration in the stomach. Indeed, as reported here, intravenous (i.v.) infusion of PAF to rats, at doses of 20-200 pmol per kg per min, resulted in the formation of extensive haemorrhagic erosions in the gastric mucosa. The ulcerogenic actions of PAF are not attributable solely to its hypotensive actions and were not mediated via effects on platelets or cyclooxygenase products, nor via histamine H1, H2 or alpha-adrenergic receptors. PAF is the most potent gastric ulcerogen yet described and its endogenous release may underlie or contribute to certain forms of gastric ulceration.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510396     DOI: 10.1038/319054a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  61 in total

1.  Role of platelet activating factor on the fibrinolytic activation in the pathogenesis of gastric mucosal damage induced by endothelin-1.

Authors:  I Kurose; S Miura; D Fukumura; H Tashiro; H Imaeda; H Shiozaki; M Suematsu; H Nagata; E Sekizuka; M Tsuchiya
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

2.  The effect of CV-3988 and CV-6209 on the acute gastric erosions of rats due to water-immersion and restraint stress.

Authors:  M Nogami; Y Hoshihara; K Tsubura; T Yamamoto; M Tabuchi; T Miyamoto; J Shiga
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

3.  Effects of inhibitors of arachidonic acid metabolism on Paf-induced gastric mucosal necrosis and haemoconcentration.

Authors:  J L Wallace; B J Whittle
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

4.  Gastrointestinal damage induced by platelet-activating factor. Inhibition by the corticoid, dexamethasone.

Authors:  J L Wallace; B J Whittle
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

5.  Gastric damage following local intra-arterial administration of reactive oxygen metabolites in the rat.

Authors:  J V Esplugues; B J Whittle
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

6.  Platelet-activating factor: a mediator of pancreatic inflammation during cerulein hyperstimulation.

Authors:  W Zhou; B A Levine; M S Olson
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

7.  Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor.

Authors:  Zhili Xu; Jeffrey S Smith; Jie Tian; Andrew P Byrnes
Journal:  Mol Ther       Date:  2009-12-01       Impact factor: 11.454

8.  Role of neutrophils in gastric damage induced by platelet activating factor.

Authors:  A Etienne; F Thonier; F Hecquet; P Braquet
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

9.  Gastric secretion of platelet activating factor and precursors in healthy humans: effect of pentagastrin.

Authors:  I Sobhani; Y Denizot; S Hochlaf; D Rigaud; J Vatier; J Benveniste; M J Lewin; M Mignon
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

10.  Local opioid-sensitive afferent sensory neurones in the modulation of gastric damage induced by Paf.

Authors:  J V Esplugues; B J Whittle; S Moncada
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.